Uso clínico de las estatinas y objetivos terapéuticos en relación con el riesgo cardiovascular
Clinical use of statins and cholesterol goals in patients with several cardiovascular risk factors
Ana Gómez-Beldaa,
, Enrique Rodillaa, Amparo Alberta, Luis Garcíaa, Carmen Gonzálezb, José M. Pascuala
Autor para correspondencia
pascual_jma@gva.es
Correspondencia: Unidad de Hipertensión Arterial y Riesgo Cardiovascular. Servicio de Medicina Interna. Hospital de Sagunto. Avda. Ramón y Cajal, s/n. 46520 Port de Sagunt. Valencia. España.
Correspondencia: Unidad de Hipertensión Arterial y Riesgo Cardiovascular. Servicio de Medicina Interna. Hospital de Sagunto. Avda. Ramón y Cajal, s/n. 46520 Port de Sagunt. Valencia. España.
Leído
4015
Vecesse ha leído el artículo
501
Total PDF
3514
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 0 | 7 | 7 |
| 2025 10 | 0 | 6 | 6 |
| 2025 9 | 0 | 8 | 8 |
| 2025 8 | 0 | 1 | 1 |
| 2025 7 | 0 | 1 | 1 |
| 2025 6 | 0 | 4 | 4 |
| 2025 5 | 0 | 1 | 1 |
| 2025 3 | 0 | 2 | 2 |
| 2025 2 | 0 | 6 | 6 |
| 2025 1 | 0 | 8 | 8 |
| 2024 12 | 0 | 1 | 1 |
| 2024 10 | 0 | 3 | 3 |
| 2024 9 | 0 | 1 | 1 |
| 2024 7 | 0 | 6 | 6 |
| 2024 4 | 0 | 1 | 1 |
| 2024 3 | 0 | 11 | 11 |
| 2024 2 | 0 | 10 | 10 |
| 2024 1 | 0 | 4 | 4 |
| 2023 12 | 0 | 9 | 9 |
| 2023 11 | 0 | 17 | 17 |
| 2023 10 | 0 | 11 | 11 |
| 2023 9 | 0 | 1 | 1 |
| 2023 7 | 0 | 8 | 8 |
| 2023 6 | 0 | 2 | 2 |
| 2023 5 | 0 | 2 | 2 |
| 2023 4 | 0 | 1 | 1 |
| 2023 3 | 0 | 2 | 2 |
| 2023 2 | 0 | 8 | 8 |
| 2022 1 | 0 | 2 | 2 |
| 2022 12 | 5 | 5 | 10 |
| 2022 11 | 0 | 2 | 2 |
| 2022 9 | 0 | 8 | 8 |
| 2022 8 | 0 | 6 | 6 |
| 2022 6 | 0 | 2 | 2 |
| 2022 5 | 0 | 2 | 2 |
| 2022 4 | 1 | 2 | 3 |
| 2022 3 | 0 | 2 | 2 |
| 2021 12 | 0 | 1 | 1 |
| 2021 11 | 0 | 1 | 1 |
| 2021 10 | 0 | 2 | 2 |
| 2021 7 | 0 | 1 | 1 |
| 2021 3 | 0 | 5 | 5 |
| 2021 2 | 0 | 1 | 1 |
| 2020 12 | 0 | 1 | 1 |
| 2020 9 | 0 | 2 | 2 |
| 2020 8 | 0 | 2 | 2 |
| 2020 7 | 0 | 1 | 1 |
| 2020 6 | 3 | 3 | 6 |
| 2020 5 | 0 | 3 | 3 |
| 2020 3 | 0 | 1 | 1 |
| 2020 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 7 | 7 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 0 | 1 | 1 |
| 2019 8 | 0 | 5 | 5 |
| 2019 7 | 0 | 12 | 12 |
| 2019 6 | 0 | 9 | 9 |
| 2019 5 | 0 | 17 | 17 |
| 2019 4 | 0 | 17 | 17 |
| 2019 3 | 0 | 3 | 3 |
| 2019 2 | 0 | 2 | 2 |
| 2019 1 | 0 | 2 | 2 |
| 2018 12 | 0 | 6 | 6 |
| 2018 11 | 0 | 5 | 5 |
| 2018 10 | 0 | 3 | 3 |
| 2017 10 | 3 | 2 | 5 |
| 2017 9 | 11 | 7 | 18 |
| 2017 8 | 16 | 1 | 17 |
| 2017 7 | 10 | 3 | 13 |
| 2017 6 | 12 | 4 | 16 |
| 2017 5 | 28 | 3 | 31 |
| 2017 4 | 10 | 1 | 11 |
| 2017 3 | 16 | 11 | 27 |
| 2017 2 | 9 | 1 | 10 |
| 2016 1 | 9 | 1 | 10 |
| 2016 12 | 36 | 4 | 40 |
| 2016 11 | 68 | 6 | 74 |
| 2016 10 | 70 | 8 | 78 |
| 2016 9 | 22 | 6 | 28 |
| 2016 8 | 17 | 4 | 21 |
| 2016 7 | 26 | 3 | 29 |
| 2016 6 | 49 | 7 | 56 |
| 2016 5 | 38 | 7 | 45 |
| 2016 4 | 33 | 9 | 42 |
| 2016 3 | 38 | 1 | 39 |
| 2016 2 | 38 | 6 | 44 |
| 2015 1 | 31 | 7 | 38 |
| 2015 12 | 40 | 5 | 45 |
| 2015 11 | 60 | 3 | 63 |
| 2015 10 | 121 | 9 | 130 |
| 2015 9 | 42 | 3 | 45 |
| 2015 8 | 49 | 4 | 53 |
| 2015 7 | 29 | 5 | 34 |
| 2015 6 | 14 | 5 | 19 |
| 2015 5 | 31 | 6 | 37 |
| 2015 4 | 38 | 8 | 46 |
| 2015 3 | 29 | 3 | 32 |
| 2015 2 | 31 | 2 | 33 |
| 2015 1 | 36 | 3 | 39 |
| 2014 12 | 69 | 5 | 74 |
| 2014 11 | 47 | 3 | 50 |
| 2014 10 | 49 | 0 | 49 |
| 2014 9 | 64 | 1 | 65 |
| 2014 8 | 50 | 4 | 54 |
| 2014 7 | 50 | 3 | 53 |
| 2014 6 | 53 | 1 | 54 |
| 2014 5 | 39 | 2 | 41 |
| 2014 4 | 35 | 4 | 39 |
| 2014 3 | 32 | 2 | 34 |
| 2014 2 | 38 | 2 | 40 |
| 2014 1 | 39 | 3 | 42 |
| 2013 12 | 46 | 5 | 51 |
| 2013 11 | 42 | 3 | 45 |
| 2013 10 | 43 | 3 | 46 |
| 2013 9 | 32 | 6 | 38 |
| 2013 8 | 36 | 3 | 39 |
| 2013 7 | 41 | 2 | 43 |
| 2013 6 | 3 | 0 | 3 |
| 2003 10 | 1587 | 0 | 1587 |
Mostrar todo
